[{"Assets_0_Q1_USD":477114000.0,"CommonStockSharesConverted_0_Q1_shares":108350368.0,"CommonStockSharesOutstanding_0_Q1_shares":108350368.0,"EarningsPerShareBasic_1_Q1_USD":-0.71,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-48409000.0,"NetIncomeLossConverted_1_Q1_USD":-77240000.0,"RevenuesConverted_1_Q1_USD":5718000.0,"StockholdersEquity_0_Q1_USD":380333000.0,"Ticker":"VIR","CIK":"1706431","name":"VIR BIOTECHNOLOGY, INC.","OfficialName":"Vir Biotechnology Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3076942595.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200512"}]